Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase01:11

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase

69
Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...
69
Cancer Survival Analysis01:21

Cancer Survival Analysis

844
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
844
Treatment Resistent Cancers02:56

Treatment Resistent Cancers

1.5K
1.5K
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

6.4K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
6.4K
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

3.9K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.9K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

9.2K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
9.2K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Evolution of the New York State Cystic Fibrosis Newborn Screening Algorithm: Two Decades of Experience.

Pediatric pulmonology·2026
Same author

Multivariate analysis of ecotypic responses of Scrophularia striata to germination-enhancing treatments.

BMC plant biology·2026
Same author

Candida vulvovaginitis treatment: A comparative clinical trial of clotrimazole and prangos ferulacea (Jashir) vaginal creams.

Complementary therapies in medicine·2026
Same author

From quantum feature maps to quantum reservoir computing: an applicative perspective.

Philosophical transactions. Series A, Mathematical, physical, and engineering sciences·2026
Same author

Quantum feedback-enhanced discord in T-shaped plasmonic waveguides with embedded cavity.

Scientific reports·2026
Same author

Radiofrequency radiation from mobile phones and the risk of breast cancer: A multicenter case-control study with an additional suspected comparison group.

Journal of research in medical sciences : the official journal of Isfahan University of Medical Sciences·2026
Same journal

Expression of Transforming Growth Factor Beta 1 in Lung Adenocarcinoma and Its Relationship with Circulating Tumour Cells.

Biochemical genetics·2026
Same journal

The Role of Exercise in Regulating Histone Modifications and Non-coding RNAs in Muscle Aging and Sarcopenia.

Biochemical genetics·2026
Same journal

VALD-3 Induces GSDME-Dependent Pyroptosis via ROS/JNK/Bax Pathway in Triple-Negative Breast Cancer Cells.

Biochemical genetics·2026
Same journal

Correlation Between SGK1 Expression Level and Multiple Myeloma Progression After Autologous Hematopoietic Stem Cell Transplantation.

Biochemical genetics·2026
Same journal

Decoding Genetic Risk Factors in Recurrent Pregnancy Loss: An Integrative Chromosomal and Bioinformatics Approach.

Biochemical genetics·2026
Same journal

Chromosome-Level Genome Assembly of the Sea Urchin Glyptocidaris crenularis and Sex Chromosome Identification.

Biochemical genetics·2026
See all related articles

Related Experiment Video

Updated: Apr 13, 2026

Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma
04:09

Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma

Published on: October 10, 2018

8.9K

Whole-Genome Deep Learning Predicts Chemotherapy Response in Colorectal Cancer.

Hossein Sadeghi1, Fatemeh Seif2

  • 1Department of Physics, Faculty of Sciences, Arak University, Arak, 38156-8-8349, Iran. H-Sadeghi@araku.ac.ir.

Biochemical Genetics
|April 11, 2026
PubMed
Summary
This summary is machine-generated.

This study introduces a deep learning model to predict colorectal cancer (CRC) chemotherapy response using genomic data. The AI framework accurately identifies patients likely to resist treatment, improving precision oncology.

Keywords:
Chemotherapy response predictionColorectal cancer genomicsDeep learningPrecision oncologyWhole-genome sequencing

More Related Videos

Comparison of Predictive Performance of Three Lymph Node Staging Systems in Colorectal Signet Ring Cell Carcinoma Based on Machine Learning Model
07:13

Comparison of Predictive Performance of Three Lymph Node Staging Systems in Colorectal Signet Ring Cell Carcinoma Based on Machine Learning Model

Published on: April 18, 2025

870
Mining Spatial Transcriptomics Datasets using DeepSpaceDB
10:16

Mining Spatial Transcriptomics Datasets using DeepSpaceDB

Published on: September 5, 2025

1.1K

Related Experiment Videos

Last Updated: Apr 13, 2026

Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma
04:09

Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma

Published on: October 10, 2018

8.9K
Comparison of Predictive Performance of Three Lymph Node Staging Systems in Colorectal Signet Ring Cell Carcinoma Based on Machine Learning Model
07:13

Comparison of Predictive Performance of Three Lymph Node Staging Systems in Colorectal Signet Ring Cell Carcinoma Based on Machine Learning Model

Published on: April 18, 2025

870
Mining Spatial Transcriptomics Datasets using DeepSpaceDB
10:16

Mining Spatial Transcriptomics Datasets using DeepSpaceDB

Published on: September 5, 2025

1.1K

Area of Science:

  • Genomics
  • Computational Biology
  • Oncology

Background:

  • Colorectal cancer (CRC) chemotherapy response is highly variable.
  • Existing clinical predictors do not fully account for genomic factors influencing resistance.
  • There is a need for advanced methods to predict treatment outcomes in CRC.

Purpose of the Study:

  • To develop and validate a hybrid deep learning framework for predicting chemotherapy response in colorectal cancer.
  • To identify novel genomic predictors of chemotherapy resistance.
  • To advance precision oncology by improving treatment response prediction in CRC.

Main Methods:

  • Integrated analysis of whole-genome somatic mutations, evolutionary conservation, chromatin accessibility, and 3D genome architecture.
  • Utilized a hybrid deep learning model combining convolutional neural networks (CNNs) and bidirectional long short-term memory (BiLSTM) networks.
  • Employed an attention mechanism to identify key predictive genomic regions across 2,546 TCGA patient samples.

Main Results:

  • The deep learning model achieved high accuracy, with an AUC of 0.92 in cross-validation and 0.88 in independent validation.
  • The model significantly outperformed traditional clinical prediction models (ΔAUC = +0.18, p < 0.001).
  • Identified non-coding variants in TP53, KRAS, and PIK3CA regulatory regions as critical predictors; triple-positive patients showed significantly worse progression-free survival (HR = 4.7, p < 0.001).

Conclusions:

  • The developed deep learning framework accurately predicts chemotherapy response in colorectal cancer.
  • Novel non-coding genomic regions associated with treatment resistance have been uncovered.
  • This work represents a significant advancement in precision oncology for CRC management.